本拉利祖马布在严重的乙酸性喘中:来自土耳其的真实数据
Zeynep Çelebi Sözener1, Betül Özdel Öztürk1, Ece Şahinoğlu1
1Ankara University Faculty of Medicine, Department of Chest Diseases, Division of Immunology and Allergic Diseases, Ankara.
Respiratory medicine
|August 30, 2025
概括
贝纳利祖马布显著改善了严重酸性喘 (SEA) 患者的喘控制,肺功能和生活质量. 实践数据证实了其在减少恶化和口服皮质类固醇使用方面的有效性.
科学领域:
- 肺病学
- 免疫学
- 药理学
背景情况:
- 本拉利祖马布向IL-5α受体,用于治疗严重的酸性喘 (SEA).
- 关于本拉利祖马布在SEA中的有效性的现实数据有限.
- 这项研究评估了本拉利祖马布在现实生活中的临床效用.
研究的目的:
- 评估本拉利祖马布在SEA患者中的实际有效性.
- 评估临床结果,包括控制喘,肺功能和生活质量.
- 确定对恶化的影响和口服皮质类固醇 (OCS) 的使用.
主要方法:
- 对接受本拉利祖马布治疗的SEA患者进行多中心观察研究.
- 临床评价:ACT,肺功能测试,血液中的乙氨基基,OCS使用,恶化,AQLQ,SNOT-22.
- 在基线和8,24和52周收集的数据.
主要成果:
- 喘控制测试 (ACT) 和喘生活质量问卷 (AQLQ) 的得分显著改善.
- 显著减少临床显著的恶化和口服皮质类固醇的使用.
- 改善了肺功能 (FEV1,FEF25- 75) 和抑制了血液中乙细胞的数量.
- 整体响应率高 (第24周为89. 3%,第52周为78. 2%).
结论:
- 在实际的SEA治疗中,本拉利祖马布具有显著的临床和功能益处.
- 这项研究支持本拉利祖马布在改善喘控制和患者报告的结果方面的有效性.
- 在SEA患者中,本拉利祖马布有效降低了恶化和OCS依赖.
相关概念视频
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
451
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
451
Antiasthma Drugs: Leukotriene Modifiers
461
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
461
Asthma-IV: Diagnostic and Management
2.6K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.6K
Antiasthma Drugs: β2-Adrenoceptor Agonists
377
Bronchodilators are critical in managing asthma, a chronic respiratory condition characterized by airway constriction due to inflammation and hyper-reactivity. Specifically, bronchodilators ease this constriction by relaxing the bronchial muscles, facilitating easier breathing.
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
377
Asthma: Pathogenesis and Management
576
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
576
Asthma-II: Pathophysiology and Classification
2.8K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.8K


